Karen Israel - Concepedia

Author

Karen Israel

The University of Texas at Austin

Also Known As

K Israel, K S Israel, K. Israel, K. S. ISRAEL, K. S. Israel, KAREN S. ISRAEL, Karen Israel, Karen S. Israel

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

The University of Texas at Austin Indiana University School of Medicine Indiana University – Purdue University Indianapolis

About

Karen Israel is an author at The University of Texas at Austin specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	821
2	Immunology	3	3	435
3	Microbiology	2	2	97
4	Health Sciences	1	1	30
5	Cell Biology	1	1	142

Karen Israel

Publications

Citations

H-Index

Page 1

	Year	Citations
Histoplasmosis in immunosuppressed patients Carol A. Kauffman, Karen Israel, James W. Smith, The American Journal of Medicine Immunosuppressive TherapyImmunologyHematologyPathologyHistopathology	1978	244
Itraconazole treatment of phaeohyphomycosis P. K. Sharkey, John R. Graybill, Michael G. Rinaldi, Journal of the American Academy of Dermatology Diagnostic MycologyAntifungal AgentAntifungal AgentsClinical MycologyDermatology	1990	212
Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Weiping Yu, Karen Israel, Qiao Liao, PubMed Breast OncologyChemoprevention StrategyApoptosisImmunologyCell Death	1999	142
Vitamin E Succinate Induces Apoptosis in Human Prostate Cancer Cells: Role for Fas in Vitamin E Succinate-Triggered Apoptosis Karen Israel, Weiping Yu, Bob G. Sanders, Nutrition and Cancer	2000	141
RRR‐α‐tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways Karen Israel, Bob G. Sanders, Kimberly A. Kline Nutrition and Cancer	1995	87
Bactericidal and Opsonic Activity against Neisseria gonorrhoeae in Sera from Patients with Disseminated Gonococcal Infection George F. Brooks, Karen Israel, B H Petersen The Journal of Infectious Diseases Microbial DiseaseC8 DeficiencyOther IsolatesPathogenesisHealthcare-associated Infection	1976	67
Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome Steve Norris, Joseph Wheat, D. S. McKinsey, The American Journal of Medicine Primary ImmunodeficiencyAcquired Immunodeficiency SyndromeImmunologyClinical MycologyHiv	1994	49
Disulfiram-like Reaction to -Lactams M. K. Buening, J. S. Wold, Karen Israel, JAMA Medicinal ChemistryMedicineDisulfiram-like ReactionPoisoningClinical Pharmacology	1981	34
Pharmacology of Cinoxacin in Humans Henry R. Black, Karen Israel, Robert L. Wolen, Antimicrobial Agents and Chemotherapy Unchanged DrugPharmacotherapyAntimicrobial ChemotherapyAntibiotic ResistanceDrug Resistance	1979	30
Effect of probenecid on the pharmacokinetics of moxalactam K A DeSante, Karen Israel, Gordon Brier, Antimicrobial Agents and Chemotherapy UrologyPlasma Elimination Half-lifeRenal FunctionMedicineBioanalysis	1982	25

Page 1